Mark Ragosa Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Mark Ragosa is CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 23,382 shares of KNSA, which is worth approximately $539,890. The most recent transaction as insider was on Mar 21, 2022, when has been sold 1,047 shares (Class A Common Share) at a price of $10.98 per share, resulting in proceeds of $11,496. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.4K

1.85% 3M change

49.58% 12M change

Total Value Held $539,890

Mark Ragosa Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 21 2022	SELL Payment of exercise price or tax liability	$11,496 $10.98 p/Share	1,047 Reduced 15.64%	5,648 Class A Common Share
Mar 21 2022	BUY Exercise of conversion of derivative security	-	3,019 Added 31.08%	6,695 Class A Common Share
Mar 16 2022	SELL Payment of exercise price or tax liability	$3,069 $10.13 p/Share	303 Reduced 7.61%	3,676 Class A Common Share
Mar 16 2022	BUY Exercise of conversion of derivative security	-	872 Added 17.98%	3,979 Class A Common Share
Dec 31 2020	SELL Payment of exercise price or tax liability	$22,918 $17.67 p/Share	1,297 Reduced 29.45%	3,107 Class A Common Share
Dec 31 2020	BUY Exercise of conversion of derivative security	-	4,404 Added 50.0%	4,404 Class A Common Share

Mark Ragosa

CHIEF FINANCIAL OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account